These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 4343629

  • 1. Actions of papaverine and bulbocapnine on synaptic transmission in the nigro-striatal pathway in the rat.
    Gonzalez-Vegas JA.
    J Physiol; 1972 Oct; 226(2):102P. PubMed ID: 4343629
    [No Abstract] [Full Text] [Related]

  • 2. Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.
    Gonzalez-Vegas JA.
    Brain Res; 1974 Nov 15; 80(2):219-28. PubMed ID: 4371023
    [No Abstract] [Full Text] [Related]

  • 3. [Some aspects of the physiological role of dopamine as a synaptic transmitter in basal ganglia and caudate nucleus].
    Kostowski W.
    Acta Physiol Pol; 1972 Nov 15; 23():97-114. PubMed ID: 4338739
    [No Abstract] [Full Text] [Related]

  • 4. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J, Magelund G, Olianas MC.
    Adv Biochem Psychopharmacol; 1981 Nov 15; 30():165-86. PubMed ID: 7036675
    [No Abstract] [Full Text] [Related]

  • 5. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF, Moore KE.
    Brain Res; 1971 Dec 24; 35(2):580-3. PubMed ID: 5135554
    [No Abstract] [Full Text] [Related]

  • 6. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C, Weiss M, Rostain JC.
    Exp Neurol; 2008 Jul 24; 212(1):63-70. PubMed ID: 18452916
    [Abstract] [Full Text] [Related]

  • 7. The neuroleptics. 2. Neurophysiology and neuropharmacology.
    Albe-Fessard D, Bradley PB, Gerschenfeld HM, Herz A, Krnjević K, Lodin Z, Marczynski TJ, Massion J, Meulders M, Poirier LJ, Salmoiraghi GC, Schlag J, Tauc L, Wall PD.
    Mod Probl Pharmacopsychiatry; 1970 Jul 24; 5():12-22. PubMed ID: 4348144
    [No Abstract] [Full Text] [Related]

  • 8. Electrophysiological studies of GABAergic neurons in the basal ganglia: nigro-collicular, nigro-thalamic, and pallido-subthalamic neurons.
    Feger J.
    Adv Biochem Psychopharmacol; 1981 Jul 24; 30():53-68. PubMed ID: 7331936
    [No Abstract] [Full Text] [Related]

  • 9. Recent finding on dopaminergic transmission in the basal ganglia.
    Glowinski J.
    Adv Neurol; 1990 Jul 24; 53():67-73. PubMed ID: 2173377
    [No Abstract] [Full Text] [Related]

  • 10. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K, Casu M.
    Mol Cell Biochem; 1981 Sep 25; 39():369-405. PubMed ID: 6118827
    [No Abstract] [Full Text] [Related]

  • 11. Lesions of the nigro-striatal dopamine pathway: effects on the storage and metabolism of striatal dopamine.
    Goldstein M, Ceasar P, Anagnoste B.
    Pharmacol Ther B; 1976 Sep 25; 2(1):89-95. PubMed ID: 131326
    [No Abstract] [Full Text] [Related]

  • 12. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication.
    Calabresi P, Ammassari-Teule M, Gubellini P, Sancesario G, Morello M, Centonze D, Marfia GA, Saulle E, Passino E, Picconi B, Bernardi G.
    Neurobiol Dis; 2001 Jun 25; 8(3):419-32. PubMed ID: 11442351
    [Abstract] [Full Text] [Related]

  • 13. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A, Fowler LJ, Oakley NR, Simmonds MA, Tanner T.
    Neuropharmacology; 1977 Jun 25; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract] [Full Text] [Related]

  • 14. Electrophysiology of the nigro-putamen dopamine pathway.
    York DH.
    Pharmacol Ther B; 1976 Jun 25; 2(1):1-7. PubMed ID: 772715
    [No Abstract] [Full Text] [Related]

  • 15. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct 25; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 16. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA, Riquelme LA, Murer MG.
    Eur J Neurosci; 2007 May 25; 25(9):2791-804. PubMed ID: 17561844
    [Abstract] [Full Text] [Related]

  • 17. Nigro-neostriatal projection. A correlative study with Fink-Heimer impregnation, fluorescence histochemistry and electron microscopy.
    Ibata Y, Nojyo Y, Matsuura T, Sano Y.
    Z Zellforsch Mikrosk Anat; 1973 Apr 17; 138(3):333-44. PubMed ID: 4574742
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Distinct regional differences in dopamine-mediated volume transmission.
    Rice ME.
    Prog Brain Res; 2000 Apr 17; 125():277-90. PubMed ID: 11098664
    [No Abstract] [Full Text] [Related]

  • 20. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.